2009
DOI: 10.1016/j.bmcl.2009.10.058
|View full text |Cite
|
Sign up to set email alerts
|

Novel pyrazolopyrimidines as highly potent B-Raf inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(13 citation statements)
references
References 10 publications
0
13
0
Order By: Relevance
“…All additional information pertaining to characterization of the compounds using synthesis of pyrazolo [1,5a]pyrimidine derivatives (Schemes S1-6), 1H-NMR spectra ( Figures S1, 3, 4, 7, 9, 11, 13, 15, 17, 19, 20, 22, 24, 26), Mass spectrum ( Figure S6), 13C-NMR spectra (Figures S2,5,8,10,12,14,16,18,21,23,25,27) are given in Supplementary Information. The recovery and recycling of deep eutectic solvent (Table S1), Optimization of solvent and catalysts for the synthesis of dioxo pyrrolidones and dioxoisoindol (Table S2), antibacterial activity of compounds (Table S3) and antifungal activity of compounds (Table S4) are also given in the Supporting Information, available at www.ias.ac.in/ chemsci.…”
Section: Supplementary Information (Si)mentioning
confidence: 99%
“…All additional information pertaining to characterization of the compounds using synthesis of pyrazolo [1,5a]pyrimidine derivatives (Schemes S1-6), 1H-NMR spectra ( Figures S1, 3, 4, 7, 9, 11, 13, 15, 17, 19, 20, 22, 24, 26), Mass spectrum ( Figure S6), 13C-NMR spectra (Figures S2,5,8,10,12,14,16,18,21,23,25,27) are given in Supplementary Information. The recovery and recycling of deep eutectic solvent (Table S1), Optimization of solvent and catalysts for the synthesis of dioxo pyrrolidones and dioxoisoindol (Table S2), antibacterial activity of compounds (Table S3) and antifungal activity of compounds (Table S4) are also given in the Supporting Information, available at www.ias.ac.in/ chemsci.…”
Section: Supplementary Information (Si)mentioning
confidence: 99%
“…Although these compounds bind to the dopamine in vitro , their behavioral effects are generally different from those of the typical dopamine uptake inhibitors, of which cocaine is a prototype . Recently, interest has been directed towards the construction of a tropane scaffold attached to heterocyclic residue as a substituent or in a fused ring system, for example, pyrazolo[1,5‐ a ]pyrimidines which are shown to be potent B‐Raf inhibitors .…”
Section: Introductionmentioning
confidence: 99%
“…In addition, several pyrazolopyrimidines have proved to elicit inhibitory activity on the growth of several human tumor cell lines besides being active against cyclin dependent kinases (CDKs) 21–23, Moreover, purine derivatives such as olomoucine and roscovitine; structurally related to pyrazolopyrimidines, were found to exhibit moderate activity but good selectivity toward several CDKs 24. Furthermore, some pyrazolopyrimidines proved to possess potent inhibitory activity against other enzymes that contribute to the cell cycle such as glycogen synthase kinase‐3 25, 26 and B‐Raf kinase 27, 28.…”
Section: Introductionmentioning
confidence: 99%